BIA
EBS icon

Bell Investment Advisors’s Emergent Biosolutions EBS Stock Holding History

Bell Investment Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15
Closed – – 1784
2022
Q2 		$0 Buy
+15
New +$512 ﹤0.01% 1752
2021
Q4 		$3K Buy
58
+41
+241% +$1.85K ﹤0.01% 964
2021
Q3 		$1K Buy
+17
New +$1.03K ﹤0.01% 1353

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bell Investment Advisors's EBS Position: Q3 2022 in Review

Bell Investment Advisors sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 15 shares.

Bell Investment Advisors first reported a position in EBS in Q3 2021 and held it in 3 quarters. The position peaked at $3K in Q4 2021. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • Bell Investment Advisors reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • Bell Investment Advisors sold 15 Emergent Biosolutions shares in Q3 2022.
  • Bell Investment Advisors first reported a position in Emergent Biosolutions in Q3 2021 and held it in 3 quarters.
  • Bell Investment Advisors's Emergent Biosolutions position peaked at $3K in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Bell Investment Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.